Logo image of AWIN

AERWINS TECHNOLOGIES INC (AWIN) Stock Fundamental Analysis

NASDAQ:AWIN - Nasdaq - US00810J2078 - Common Stock - Currency: USD

1.74  -1.6 (-47.9%)

After market: 1.83 +0.09 (+5.17%)

Fundamental Rating

0

Overall AWIN gets a fundamental rating of 0 out of 10. We evaluated AWIN against 65 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of AWIN have multiple concerns. AWIN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AWIN had negative earnings in the past year.
AWIN had a negative operating cash flow in the past year.
AWIN Yearly Net Income VS EBIT VS OCF VS FCFAWIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -5M -10M -15M -20M -25M

1.2 Ratios

The Return On Assets of AWIN (-2430.97%) is worse than 98.44% of its industry peers.
Industry RankSector Rank
ROA -2430.97%
ROE N/A
ROIC N/A
ROA(3y)-880.36%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AWIN Yearly ROA, ROE, ROICAWIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -5K -10K -15K -20K -25K

1.3 Margins

AWIN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AWIN Yearly Profit, Operating, Gross MarginsAWIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -50 -100 -150

More info and screens

0

2. Health

2.1 Basic Checks

AWIN has more shares outstanding than it did 1 year ago.
The debt/assets ratio for AWIN is higher compared to a year ago.
AWIN Yearly Shares OutstandingAWIN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 200K 400K 600K
AWIN Yearly Total Debt VS Total AssetsAWIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

AWIN has an Altman-Z score of -130.69. This is a bad value and indicates that AWIN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AWIN (-130.69) is worse than 93.75% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -130.69
ROIC/WACCN/A
WACCN/A
AWIN Yearly LT Debt VS Equity VS FCFAWIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 10M -10M

2.3 Liquidity

A Current Ratio of 0.08 indicates that AWIN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.08, AWIN is doing worse than 98.44% of the companies in the same industry.
A Quick Ratio of 0.08 indicates that AWIN may have some problems paying its short term obligations.
With a Quick ratio value of 0.08, AWIN is not doing good in the industry: 98.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
AWIN Yearly Current Assets VS Current LiabilitesAWIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.02% over the past year.
AWIN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)6.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.25%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%48.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y111.11%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year76.14%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AWIN Yearly Revenue VS EstimatesAWIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AWIN Yearly EPS VS EstimatesAWIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 0 -5 -10 -15 -20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AWIN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 85.29, which means the current valuation is very expensive for AWIN.
AWIN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AWIN is more expensive than 62.50% of the companies in the same industry.
AWIN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.38.
Industry RankSector Rank
PE N/A
Fwd PE 85.29
AWIN Price Earnings VS Forward Price EarningsAWIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AWIN Per share dataAWIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AWIN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AERWINS TECHNOLOGIES INC

NASDAQ:AWIN (6/18/2024, 8:14:32 PM)

After market: 1.83 +0.09 (+5.17%)

1.74

-1.6 (-47.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners255.89%
Ins Owner Change0%
Market Cap1.60M
Analysts82.86
Price Target1.02 (-41.38%)
Short Float %0.15%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-102.73%
Min Revenue beat(2)-106.04%
Max Revenue beat(2)-99.42%
Revenue beat(4)0
Avg Revenue beat(4)-76.3%
Min Revenue beat(4)-106.04%
Max Revenue beat(4)-1.94%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 85.29
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-45.4
EYN/A
EPS(NY)0.02
Fwd EY1.17%
FCF(TTM)-7.15
FCFYN/A
OCF(TTM)-7.15
OCFYN/A
SpS0
BVpS-20.09
TBVpS-20.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2430.97%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-880.36%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -130.69
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.25%
EPS Next Y111.11%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%48.24%
Revenue Next Year76.14%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-799700%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61%
OCF growth 3YN/A
OCF growth 5YN/A